Paper984072
Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension.
Beretta-Piccoli C and 3 others. Am J Med, 1976. Cited by 85 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension. Papers, record 984072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/984072
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Volume | Major topic |
| Hypertension | Major topic |
| Kidney Diseases | Major topic |
| Renin | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sodium | |
| Time Factors | |
| Water-Electrolyte Imbalance |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,684,653 | Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus-Clinical Practice Position Statement of the Polish Society of Nephrology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684653 | PubMed |
| 37,629,226 | Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease-Clinical Practice Position Statement of the Polish Society of Nephrology. | J Clin Med | 2023 | https://conductscience.org/library/papers/37629226 | PubMed |
| 36,127,661 | Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial. | BMC Nephrol | 2022 | https://conductscience.org/library/papers/36127661 | PubMed |
| 31,258,795 | DETERMINATION OF VOLUME OVERLOAD BY BIOELECTRICAL IMPEDANCE ANALYSIS AND NT-PROBNP IN DIABETIC PRE-DIALYSIS PATIENTS. | Acta Endocrinol (Buchar) | 2016 | https://conductscience.org/library/papers/31258795 | PubMed |
| 22,235,821 | A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. | J Clin Hypertens (Greenwich) | 2012 | https://conductscience.org/library/papers/22235821 | PubMed |
| 7,512,464 | Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure. | Drugs | 1993 | https://conductscience.org/library/papers/7512464 | PubMed |
| 7,453,095 | Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7453095 | PubMed |
| 6,991,789 | Hypoaldosteronism without hyperkalemia. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6991789 | PubMed |
| 6,790,017 | Sodium and potassium in essential hypertension. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6790017 | PubMed |
| 6,756,933 | Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6756933 | PubMed |
| 4,093,273 | Blood pressure may be sodium-dependent in diabetic patients without overt nephropathy. | Ir J Med Sci | 1985 | https://conductscience.org/library/papers/4093273 | PubMed |
| 3,154,671 | Renal protective effects of calcium antagonists? | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154671 | PubMed |
| 2,850,905 | Renal protective effect of long term antihypertensive therapy with enalapril. | Drugs | 1988 | https://conductscience.org/library/papers/2850905 | PubMed |
| 895,008 | Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man. | Klin Wochenschr | 1977 | https://conductscience.org/library/papers/895008 | PubMed |
| 397,972 | Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/397972 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/984072
GET https://conductscience.org/api/papers/v1/984072/authors